Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,410 | -95,478 | -70,303 | -2,518 | -46,979 |
| Depreciation Amortization | -758 | -157 | 5 | -221 | N/A |
| Accounts payable and accrued liabilities | 361 | 60 | 4,938 | -155 | 1,290 |
| Other Working Capital | -8,197 | 2,341 | 3,406 | -827 | 10,509 |
| Other Operating Activity | 41,315 | 32,194 | 23,038 | 1,340 | 12,566 |
| Operating Cash Flow | $-94,689 | $-61,040 | $-38,916 | $-2,381 | $-22,614 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,384 | -148,651 | N/A | 12,850 | N/A |
| PPE Investments | -196 | -193 | -136 | N/A | N/A |
| Purchase Of Investment | -261,194 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-247,006 | $-148,844 | $-136 | $12,850 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 360,228 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | 95,000 |
| Common Stock Issued | 384 | 190,452 | N/A | N/A | N/A |
| Other Financing Activity | 156 | 156 | 190,608 | 0 | -3,000 |
| Financing Cash Flow | $360,768 | $190,608 | $190,608 | $N/A | $92,000 |
| Exchange Rate Effect | -21 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 69,386 | 69,386 | 69,386 | 33,751 | N/A |
| End Cash Position | 88,438 | 50,106 | 220,942 | 44,220 | 69,386 |
| Net Cash Flow | $19,052 | $-19,280 | $151,556 | $10,469 | $69,386 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,689 | -61,040 | -38,916 | -2,381 | -22,614 |
| Capital Expenditure | -196 | -193 | -136 | N/A | N/A |
| Free Cash Flow | -94,885 | -61,233 | -39,052 | -2,381 | -22,614 |